This article presents guidelines on the diagnosis and management of advanced stage lung cancer developed by the ESMO in 2013.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Lung
July 26, 2014
This article summarizes consensus guidelines for the diagnosis and management of early stage lung cancer developed by ESMO in 2013.
July 16, 2014
Spontaneous pneumothorax is often treated with a large bore chest tube placement and hospitalization. This article presents a reproducible education model for treating spontaneous pneumothorax with a percutaneous catheter and water seal/collection device.
July 12, 2014
This editorial, authored by a number of presidents/leaders of prominent medical societies, laments a recent position paper of the ESMO espousing medical oncologists as the natural team leaders of multidisciplinary oncologic care. It cautions other cancer specialists not to abandon their roles as advocates for their cancer patients.
July 8, 2014
Stephanie Worrel discusses the use of lobectomy in lung cancer patients over 75 years old, and the impact robotic lobectomy has on outcomes.
July 8, 2014
This is an interesting opinion piece about misplaced fears on the part of physicians and patients/families regarding the dangers of radiation exposure as part of diagnostic imaging.
July 4, 2014
To illustrate the potential need for regional quality improvement efforts in thoracic surgery, the authors conducted a study of lung resection in Washington state using a discharge database including nearly 8,500 pts over a 12-year period. Inpatient mortality decreased over time but there was no change in the incidence of prolonged length of stay.
July 1, 2014
This single institution retrospective study compared outcomes for lobectomy and segmentectomy using propensity score matching. For 312 pts in each group, there was no difference in logoregional or overall recurrence rates. Operative mortality rates were similar for segmentectomy and lobectomy (1.2% vs 2.5%). 5-year surival rates were also similar
July 1, 2014
This randomized trial of high risk patients with small clinial stage I cancers randomized pts to sublobar resection with or without adjuvant brachytherapy. The median follow-up for 222 pts was 4.4 years. 3 year survival was identical (71%) between the groups. There was no difference in time to local recurrence. Brachytherapy did not significantly
June 30, 2014
Shanda Blackmon, Daniel Boffa, Farhood Farjah, and Gaetano Rocco discuss lung cancer screening at the 2014 STS Annual Meeting.